Participants will undergo a comprehensive neuropsychological assessment including both paper-and-pencil tests to be validated and their corresponding comparator instruments, in order to evaluate sensitivity, specificity, and convergent validity across multiple cognitive domains.
Age
18–65
Sex
FEMALE
Healthy volunteers
Accepted
You may be eligible if
Age between 18 and 65 years old
Patient with a previous documented diagnosis of non-metastatic breast cancer (only for breast cancer survivor gruop)
Patient has completed chemotherapy for at least 6 months and for a maximum of 36 months if planned (only for breast cancer survivor gruop)
Understanding of the Italian language and ability to give informed consent
You may not be if
Presence of brain metastases or history of brain radiation therapy (only for breast cancer survivor gruop)
Patient with previous diagnosis of other malignant tumors in addition to breast cancer (only for breast cancer survivor gruop)
Patient with a previous diagnosis of malignant carcinomas (only for control gruop)
Patient with a history of brain damage with unresolved neurological consequences
Patient with previous or current serious neurological pathologies
Patient with severe psychiatric conditions
Patient with systemic pathologies that could interfere with cognitive abilities
Patient taking medications that have a strong cognitive impact and that have not been stabilized for at least 4 weeks prior to enrollment
Patient with visual or hearing impairments that are not properly corrected
Patient with any disability that might compromise the validity of cognitive tests
Clareo Health | Cognitive Impairment Assessment in Breast Cancer Survivors
